Ledger.Open graph →
SEC Form D · filed July 1, 2020

Compass Therapeutics, Inc

Offering
$195.3M
Sold
$195.3M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Vered P. Bisker-Leib · Cambridge, MAExecStephen P. Squinto · Cambridge, MADirectorCarl L. Gordon · Cambridge, MADirectorThomas J. Schuetz · Cambridge, MAExec · DirectorJulie Sunderland · Cambridge, MADirectorPhilip J. Ferneau · Cambridge, MADirectorMelanie Mcdaniel · Sheridan, WYDirectorMichael Lythcott · New York, NYDirectorToshiya Otani · PALO ALTO, CAExec · DirectorDerek Yoder · Sheridan, WYDirectorAdrian Muhammad · Windermere, FLDirectorTaras Chumachenko · Moscow, 1ZExecJohn R. Totaro · New York, NYDirectorAnna M. Palmer · New York, NYDirectorCharles M. Hazard, Jr · New York, NYExec · DirectorGary J. Crittenden · Salt Lake City, X1ExecJulia J. Vander Ploeg · Salt Lake City, UTDirectorAri Newman · Dover, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗